Evaluation of the adjuvant radiation treatment-effect heterogeneity using genomic signature for locoregional relapse and long-term outcome.
Maggie C.U. Cheang(Institute of Cancer Research), Karen A. Gelmon(University of British Columbia), Tinne Laurberg(Aarhus University Hospital), Charles M. Perou(University of North Carolina at Chapel Hill), Torsten O. Nielsen(University of British Columbia), Cheng Fan(University of North Carolina at Chapel Hill), Scott Tyldesley(BC Cancer Agency), David Voduc(BC Cancer Agency), Timothy J. Whelan(Juravinski Cancer Centre)
Cited by 0
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k